Alignment Healthcare - ALHC Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last year. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ALHC shares.
View ALHC analyst ratings or view top-rated stocks.

12 Wall Street analysts have issued 12 month price objectives for Alignment Healthcare's shares. Their ALHC share price forecasts range from $10.00 to $21.00. On average, they predict the company's stock price to reach $15.64 in the next year. This suggests a possible upside of 152.2% from the stock's current price.
View analysts price targets for ALHC or view top-rated stocks among Wall Street analysts.

Alignment Healthcare's stock was trading at $11.76 at the beginning of 2023. Since then, ALHC stock has decreased by 47.3% and is now trading at $6.20.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our ALHC earnings forecast.

Alignment Healthcare, Inc. (NASDAQ:ALHC) posted its earnings results on Thursday, November, 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.09. The business had revenue of $293.47 million for the quarter, compared to analyst estimates of $276.31 million. Alignment Healthcare had a negative net margin of 10.43% and a negative trailing twelve-month return on equity of 54.46%.

ETFs with the largest weight of Alignment Healthcare (NASDAQ:ALHC) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Convergence Long/Short Equity ETF (CLSE), iShares U.S. Healthcare Providers ETF (IHF), First Trust US Equity Opportunities ETF (FPX) and Fidelity Blue Chip Growth ETF (FBCG).Fidelity Growth Opportunities ETF (FGRO).

Alignment Healthcare updated its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $429.00 million-$434.00 million, compared to the consensus revenue estimate of $420.54 million.

(ALHC) raised $490 million in an IPO on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Alignment Healthcare trades on the NASDAQ under the ticker symbol "ALHC."

Alignment Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include T. Rowe Price Investment Management Inc. (4.52%), Durable Capital Partners LP (2.01%), Brown Advisory Inc. (2.00%), Price T Rowe Associates Inc. MD (0.94%), Geode Capital Management LLC (0.91%) and Amundi (0.65%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Joseph S Konowiecki, Michael Curtis Foster, Richard A Cross, Robert Thomas Freeman, Warburg Pincus Llc and Warburg Pincus Partners Gp Llc.
View institutional ownership trends.

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALHC stock can currently be purchased for approximately $6.20.

Alignment Healthcare (NASDAQ:ALHC) has a market capitalization of $1.16 billion and generates $1.43 billion in revenue each year. The company earns $-149,550,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.

The company employs 1,037 workers across the globe.

Alignment Healthcare's mailing address is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. The official website for the company is www.alignmenthealthcare.com. The company can be reached via phone at 844-310-2247 or via email at alignmentir@westwicke.com.